Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction
BACKGROUND AND OBJECTIVE: According to high prevalence and mortality of ischemic heart disease, mention to treatment is important. Glucose–insulin–potassium (GIK) as an adjunctive treatment of ST segment elevation myocardial infarction (STEMI) has been suggested but its effects are controversial. Wh...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1eb8dbe5507a457b8b42d659bcd1d282 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1eb8dbe5507a457b8b42d659bcd1d282 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1eb8dbe5507a457b8b42d659bcd1d2822021-11-10T08:56:58ZEffect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction1561-41072251-7170https://doaj.org/article/1eb8dbe5507a457b8b42d659bcd1d2822011-11-01T00:00:00Zhttp://jbums.org/article-1-3924-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: According to high prevalence and mortality of ischemic heart disease, mention to treatment is important. Glucose–insulin–potassium (GIK) as an adjunctive treatment of ST segment elevation myocardial infarction (STEMI) has been suggested but its effects are controversial. Whereas C-reactive protein (CRP) has prognostic value, we aimed to evaluate the effect of GIK on Plasma concentrations of C-reactive protein in STEMI patients.METHODS: This randomized clinical trial enrolled 72 patients who had STEMI that were referred to Vaseie hospital of Sabzevar, Iran. Patients were categorized to two groups by block randomization and were treated with a high dose of GIK (25% glucose, 50 IU of soluble insulin per liter, and 80 m mol of potassium chloride per liter at 1 ml/kg/hour) (GIK group) or normal saline (control group) as adjunct to thrombolytic therapy. We analyzed Plasma concentrations of high-sensitivity C-reactive protein (CRP) at baseline and sequentially for 48 hours.FINDINGS: Baseline CRP)GIK=5.6±5.9,control=4.0±4.3mg/L, p=0.35 (were significantly increased to 3-fold at 48 hours in each group (GIK=16.8±2.2, control=15.5±3.2mg/L, p=0.17). There was no difference in plasma concentrations of CRP between GIK and control patients (p=0.24). Mean glucose level over 6 hours was higher in GIK group (212±13 mg/dL) than control group (142±46 mg/dL, p=0.006). CONCLUSION: In patients with acute myocardial infarction treated with streptokinase, glucose-insulin-potassium therapy offers no anti-inflammatory effect.M Hashemian,AR Vakili,A AkaberiBabol University of Medical Sciencesarticleglucoseinsulinpotassiummyocardial infarctionc-reactive proteinMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 13, Iss 6, Pp 45-51 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN FA |
topic |
glucose insulin potassium myocardial infarction c-reactive protein Medicine R Medicine (General) R5-920 |
spellingShingle |
glucose insulin potassium myocardial infarction c-reactive protein Medicine R Medicine (General) R5-920 M Hashemian, AR Vakili, A Akaberi Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction |
description |
BACKGROUND AND OBJECTIVE: According to high prevalence and mortality of ischemic heart disease, mention to treatment is important. Glucose–insulin–potassium (GIK) as an adjunctive treatment of ST segment elevation myocardial infarction (STEMI) has been suggested but its effects are controversial. Whereas C-reactive protein (CRP) has prognostic value, we aimed to evaluate the effect of GIK on Plasma concentrations of C-reactive protein in STEMI patients.METHODS: This randomized clinical trial enrolled 72 patients who had STEMI that were referred to Vaseie hospital of Sabzevar, Iran. Patients were categorized to two groups by block randomization and were treated with a high dose of GIK (25% glucose, 50 IU of soluble insulin per liter, and 80 m mol of potassium chloride per liter at 1 ml/kg/hour) (GIK group) or normal saline (control group) as adjunct to thrombolytic therapy. We analyzed Plasma concentrations of high-sensitivity C-reactive protein (CRP) at baseline and sequentially for 48 hours.FINDINGS: Baseline CRP)GIK=5.6±5.9,control=4.0±4.3mg/L, p=0.35 (were significantly increased to 3-fold at 48 hours in each group (GIK=16.8±2.2, control=15.5±3.2mg/L, p=0.17). There was no difference in plasma concentrations of CRP between GIK and control patients (p=0.24). Mean glucose level over 6 hours was higher in GIK group (212±13 mg/dL) than control group (142±46 mg/dL, p=0.006). CONCLUSION: In patients with acute myocardial infarction treated with streptokinase, glucose-insulin-potassium therapy offers no anti-inflammatory effect. |
format |
article |
author |
M Hashemian, AR Vakili, A Akaberi |
author_facet |
M Hashemian, AR Vakili, A Akaberi |
author_sort |
M Hashemian, |
title |
Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction |
title_short |
Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction |
title_full |
Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction |
title_fullStr |
Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction |
title_full_unstemmed |
Effect of Glucose–Insulin–Potassium on Plasma Concentrations of C - Reactive Protein in Acute Myocardial Infarction |
title_sort |
effect of glucose–insulin–potassium on plasma concentrations of c - reactive protein in acute myocardial infarction |
publisher |
Babol University of Medical Sciences |
publishDate |
2011 |
url |
https://doaj.org/article/1eb8dbe5507a457b8b42d659bcd1d282 |
work_keys_str_mv |
AT mhashemian effectofglucoseinsulinpotassiumonplasmaconcentrationsofcreactiveproteininacutemyocardialinfarction AT arvakili effectofglucoseinsulinpotassiumonplasmaconcentrationsofcreactiveproteininacutemyocardialinfarction AT aakaberi effectofglucoseinsulinpotassiumonplasmaconcentrationsofcreactiveproteininacutemyocardialinfarction |
_version_ |
1718440262302171136 |